首页 › 基金 › Crawford Fund Management, LLC › MRNA

Crawford Fund Management, LLC 对 MRNA 的持仓历史

MODERNA INC · 医疗保健

Crawford Fund Management, LLC 在 Q3 2026 的 13F 申报中披露持有 MRNA(MODERNA INC)79,300 股,市值约 US$15.3M,约占其申报组合的 2.46%,在其申报持仓中市值排名第 8 位。 Crawford Fund Management, LLC 最近 12 个申报季度中有 12 个季度披露了 MRNA 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q3 2026)79.30K 股
申报持仓市值$15.27M
组合权重2.46%
首次申报Q4 2023
最近变动减持
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Crawford Fund Management, LLC 对 MRNA 的持仓演变

Crawford Fund Management, LLC 于 Q4 2023 首次披露 MRNA 持仓:107,800 股(约 US$10.7M)。 该持仓在 Q2 2024 达到峰值 137,300 股,市值约 US$16.3M。 在 12 次申报中,Crawford Fund Management, LLC 6 次增持、5 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 79,300 股、市值约 US$15.3M,环比减持 -17,200 股。。 持仓曾出现大幅变动:Q3 2024 增持约 43% (随后一个季度股价下跌 38%)、Q1 2026 减持约 36% (随后一个季度股价上涨 38%)、Q2 2026 减持约 39% (随后一个季度股价上涨 175%)。

逐季持仓明细

季度股数金额变化
Q4 2023 107.80K $10.72M 新进
Q1 2024 129.10K $13.76M 增持
Q2 2024 137.30K $16.30M 增持
Q3 2024 196.60K $13.14M 增持
Q4 2024 150.60K $6.26M 减持
Q1 2025 184.60K $5.23M 增持
Q2 2025 200.10K $5.52M 增持
Q3 2025 260.60K $6.73M 增持
Q4 2025 247.00K $7.28M 减持
Q1 2026 158.20K $8.04M 减持
Q2 2026 96.50K $6.76M 减持
Q3 2026 79.30K $15.27M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 MRNA 与 13F 数据

MRNA(MODERNA INC)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 MRNA,申报仓位最大的包括:富达投资(FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford (US$2.20B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MRNA 的基金

查看 MRNA 的全部基金持有人 →

常见问题

How long has Crawford Fund Management, LLC held MRNA?

Crawford Fund Management, LLC has disclosed MRNA holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Crawford Fund Management, LLC's current position in MRNA?

As of Q3 2026, Crawford Fund Management, LLC holds 79.30K shares of MRNA (MODERNA INC), valued at $15.27M, representing 2.46% of its reported portfolio and ranking #8.

Has Crawford Fund Management, LLC been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Crawford Fund Management, LLC reduced its position in MRNA. The position peaked in Q2 2024 at 137.30K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include 富达投资(FMR), Capital World Investors, Baillie Gifford, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.